Open Access
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
NOBUHARU TAMAKI, NAMI MORI, SHINTARO TAKAKI, KEIJI TSUJI, TOSHIFUMI TADA, SHINICHIRO NAKAMURA, HIRONORI OCHI, TOSHIE MASHIBA, MASAO DOISAKI, HIROYUKI MARUSAWA, HARUHIKO KOBASHI, HIDEKI FUJII, CHIKARA OGAWA, MICHIKO NONOGI, HIROTAKA ARAI, YASUSHI UCHIDA, NAOHITO URAWA, RYOICHI NARITA, TAKEHIRO AKAHANE, MASAHIKO KONDO, YUTAKA YASUI, KAORU TSUCHIYA, NAMIKI IZUMI and MASAYUKI KUROSAKI
Anticancer Research September 2024, 44 (9) 3913-3918; DOI: https://doi.org/10.21873/anticanres.17219